Stocktoria
LEXICON PHARMACEUTICALS, INC. LXRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2000-04-07
LEXICON PHARMACEUTICALS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $49.8M | $31.1M | $1.2M | $139,000 | $298,000 |
| R&D expense | $61.1M | $84.5M | $58.9M | $52.8M | $55.0M |
| SG&A expense | $37.3M | $143.1M | $114.0M | $48.1M | $32.3M |
| Operating income | -$48.9M | -$197.1M | -$171.8M | -$100.8M | -$87.1M |
| Interest expense | — | — | — | $2.8M | $802,000 |
| Income tax | — | $0 | $0 | $0 | $0 |
| Net income | -$50.3M | -$200.4M | -$177.1M | -$101.9M | -$87.8M |
| EPS (diluted) | $-0.14 | $-0.63 | $-0.80 | $-0.62 | $-0.60 |
| Operating cash flow | -$67.9M | -$178.8M | -$161.9M | -$88.9M | -$87.0M |
| Free cash flow | -$67.9M | -$179.8M | -$162.4M | -$90.2M | -$88.2M |
| Cash & equivalents | $34.3M | $66.7M | $22.5M | $46.3M | $64.1M |
| Inventory | $281,000 | $231,000 | $381,000 | $0 | — |
| Total assets | $185.0M | $298.4M | $229.4M | $194.3M | $136.9M |
| Total liabilities | $77.4M | $152.5M | $136.3M | $77.2M | $23.3M |
| Shareholders' equity | $107.5M | $145.9M | $93.1M | $117.1M | $113.6M |
Source: SEC EDGAR filings · CIK 0001062822 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.